DMAM
CTIC

Del Mar Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Del Mar Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-9,597
Closed -$100K – 44
2013
Q2 		$100K Buy
+9,597
New +$112K 0.06% 30

Other funds holding CTIC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Del Mar Asset Management's CTIC Position: Q3 2013 in Review

Del Mar Asset Management sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2013, closing a stake of 9,597 shares — an estimated $100K sold.

Del Mar Asset Management first reported a position in CTIC in Q2 2013 and held it in 1 quarter. The position peaked at $100K in Q2 2013. 67 funds tracked by Wall St. Rank hold CTIC as of Q3 2013.

  • Del Mar Asset Management reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2013 after selling out during the quarter.
  • Del Mar Asset Management sold 9,597 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2013, an estimated $100K.
  • Del Mar Asset Management first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 1 quarter.
  • Del Mar Asset Management's CTI BioPharma Corp. (DE) Common Stock position peaked at $100K in Q2 2013.
  • 67 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2013.

Based on Del Mar Asset Management's 13F filing for Q3 2013, filed 12 Nov 2013.